p38 MAPK Inhibitor Tocriset™
Contains the listed products which can be used to selectively inhibit p38 MAPK signalling. The products are pre-dissolved in DMSO at a stock concentration of 10 mM in 0.5 ml.
Tocrisets contain 3-5 ligands supplied as lyophilized solids or pre-dissolved in DMSO at a specified concentration. Lyophilized solids have been freeze-dried (approximately 0.5-2 mg per vial) so that addition of 0.5 or 1 ml of solvent produces a stock concentration of 10 or 5 mM respectively.
Please see individual product listings for specific technical data and certificate of analysis.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
References are publications that support the products' biological activity.
If you know of a relevant reference for p38 MAPK Inhibitor Tocriset™, please let us know.
View Related Products by Target
Keywords: p38 MAPK Inhibitor Tocriset ligand sets Signal Transduction Ligand Sets
Citations for p38 MAPK Inhibitor Tocriset™
Citations are publications that use Tocris products.
Currently there are no citations for p38 MAPK Inhibitor Tocriset™. Do you know of a great paper that uses p38 MAPK Inhibitor Tocriset™ from Tocris? If so please let us know.